Bioshock: Biotechnology and Bioterrorism

Bioterrorism by Biotechnology: Implications for Clinical Medicine

Bioterrorism

Brooks NH, et al. ACC/AHA Guidelines for the management of patients with acute myocardial infarction. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: the Primary Angioplasty in Myocar-dial Infarction Study Group. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction: Myocardial Infarction Tri-Clini...

Biotechnology and Social Aspect

John Bartlett and bioterrorism.

Until 1997, the subject of bioterrorism was not discussed within the medical community and deliberately ignored in national planning efforts. Biological weapons were regarded as "morally repulsive." This complacency stemmed from a 1972 Biological Weapons Convention where all countries agreed to cease offensive biological weapons research. In the 1990s, however, the Soviet Union was discovered t...

Bioterrorism and Intelligence

The potential for bioterrorism has increased within the last 10 years; however, there are mixed arguments among critics as to how serious the president and Congress view this threat. The first question the intelligence community needs to ask is “Is the United States prepared for a biological attack?” Three areas need to be examined: the historical background of biological attacks, types of biow...